Mark Lashendock

Mark Lashendock

Director Corporate Strategy Global Engineering @ Bristol Myers Squibb

About Mark Lashendock

Mark Lashendock is the Director of Corporate Strategy for Global Engineering at Bristol-Myers Squibb Company, overseeing significant capital investments and strategic planning.

Current Role at Bristol-Myers Squibb

Mark Lashendock holds the position of Director Corporate Strategy - Global Engineering at Bristol-Myers Squibb Company. In this role, he is responsible for overseeing a capital spending budget of up to $600 million annually. His key responsibilities include ensuring these investments align with the company's overarching corporate strategy and enhance shareholder value. He also manages the Technical Operations Capital Governance Committee, maintaining alignment of capital investments with strategic objectives.

Previous Experience at TEVA Pharmaceuticals

Before his current role, Mark Lashendock served as the Sr. Director of Engineering & Technical Operations at TEVA Pharmaceuticals. His tenure at TEVA spanned from 1994 to 2007, lasting 13 years. During this time, he was instrumental in leading various engineering and technical operations, contributing significantly to the company's growth and operational efficiency.

Role at Zeneca Pharmaceuticals

From 1989 to 1994, Mark Lashendock worked at Zeneca Pharmaceuticals as a Group Leader. Over his 5-year tenure, he led various projects and teams, focusing on achieving strategic goals within the pharmaceutical sector. His leadership at Zeneca played a crucial role in various successful initiatives undertaken by the company during this period.

McNeil Consumer Products Company Experience

Mark Lashendock's early career included a role at McNeil Consumer Products Company, where he served as Group Supervisor Research & Development from 1985 to 1989. During these 4 years, he supervised R&D activities, contributing to the development of new consumer products and innovations. This role helped establish his foundation in leadership and technical operations.

Strategic and Financial Analysis Responsibilities

In his current role at Bristol-Myers Squibb, Mark Lashendock is responsible for performing strategic technical and financial analysis to shape the company's plant network landscape. He identifies enabling capital investments that support both R&D and commercial operations. Additionally, he drives site master planning globally, forecasting future capital investment requirements to align with corporate strategy.

People similar to Mark Lashendock